Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-11-001023
Filing Date
2011-05-26
Accepted
2011-05-26 16:44:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELLDEX THERAPEUTICS INC. p11-1251sc13g.htm SC 13G 328880
  Complete submission text file 0000902664-11-001023.txt   330537
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 11874613
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 152 WEST 57TH STREET, 47TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET, 47TH FLOOR NEW YORK NY 10019 212-622-7888
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

EIN.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G